Adimmune Corp. | Income Statement
Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
414,093.00
480,506.00
290,737.00
606,725.00
562,743.00
822,366
Cost of Goods Sold (COGS) incl. D&A
661,521.00
706,321.00
611,013.00
813,613.00
844,653.00
1,135,001
Gross Income
247,428.00
225,815.00
320,276.00
206,888.00
281,910.00
312,635
SG&A Expense
399,060.00
421,789.00
417,249.00
384,983.00
423,311.00
403,852
EBIT
646,488.00
647,604.00
737,525.00
591,871.00
705,221.00
716,487
Unusual Expense
-
-
-
1,200.00
131,474.00
1,337
Non Operating Income/Expense
2,477.00
13,644.00
6,183.00
7,540.00
73,065.00
91,589
Interest Expense
43,372.00
40,637.00
25,843.00
33,523.00
39,278.00
44,394
Pretax Income
664,799.00
659,054.00
731,070.00
627,563.00
776,971.00
665,914
Income Tax
64,346.00
41,013.00
51,249.00
-
-
-
Consolidated Net Income
600,453.00
618,041.00
782,319.00
627,563.00
776,971.00
665,914
Net Income
600,453.00
614,422.00
761,087.00
595,352.00
760,176.00
609,117
Net Income After Extraordinaries
600,453.00
614,422.00
761,087.00
595,352.00
760,176.00
609,117
Net Income Available to Common
600,453.00
614,422.00
761,087.00
595,352.00
760,176.00
609,117
EPS (Basic)
3.25
3.04
3.24
2.54
3.24
2.45
Basic Shares Outstanding
184,576.00
202,163.00
234,952.00
234,045.00
234,831.00
248,175.10
EPS (Diluted)
3.25
3.04
3.24
2.54
3.24
2.45
Diluted Shares Outstanding
184,576.00
202,163.00
234,952.00
234,045.00
234,831.00
248,175.10
EBITDA
351,399.00
348,172.00
432,321.00
300,124.00
413,371.00
458,356
Non-Operating Interest Income
5,515.00
2,206.00
2,785.00
991.00
1,494.00
2,041
Minority Interest Expense
-
3,619.00
21,232.00
32,211.00
16,795.00
56,797
About Adimmune
View Profile
